THE INFLUENCE OF INFLIXIMAB THERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS

by T A Raskina, O A Pirogova
Published 2013-12-01

Low bone mineral density as a risk factor for osteoporosis and ways of its correction in male patients with ankylosing spondylosis

by O. A. Pirogova, T. A. Raskina, M. V. Letaeva
Published 2014-09-01

Low bone mineral density as a risk factor for osteoporosis and ways of its correction in male patients with ankylosing spondylosis

by O. A. Pirogova, T. A. Raskina, M. V. Letaeva
Published 2014-09-01

The efficacy and safety of meloxicam (Movalis®) in the treatment of rheumatic diseases

by Tatyana Alekseyevna Raskina, M V Letayeva, O A Pirogova
Published 2012-06-01

Effect of infliximab on quality of life in patients with ankylosing spondylitis according to sf-36 questionnaire data

by Tatyana Alekseevna Raskina, O A Pirogova, Zh A Pivovarova
Published 2013-10-01

Effect of infliximab on quality of life in patients with ankylosing spondylitis according to sf-36 questionnaire data

by Tatyana Alekseevna Raskina, O A Pirogova, Zh A Pivovarova
Published 2013-10-01

EFFICIENCY OF ANTI-INFLAMMATORY THERAPY IN PATIENTS WITH ANKYLOSING SPONDYLITIS ACCORDING TO THE RESULTS OF A PROSPECTIVE FOLLOW-UP STUDY

by T. A. Raskina, O. S. Malyshenko, O. A. Pirogova, M. A. Volykova
Published 2016-09-01

Indicators of the osteoclastogenesis system in men with different clinical types of ankylosing spondylitis

by T. A. Raskina, O. A. Pirogova, O. V. Zobnina, G. A. Pintova
Published 2015-06-01